TD Cowen Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Raises Target Price to $371
Express News | Alnylam Pharmaceuticals Inc : TD Cowen Raises Target Price to $371 From $282
TD Cowen Reaffirms Their Buy Rating on Alnylam Pharma (ALNY)
Alnylam Canada Signs LOI From Pan-Canadian Pharmaceutical Alliance For The Public Reimbursement Of AMVUTTRA For The Treatment Of Hereditary Transthyretin-Mediated Amyloidosis In Adults
Express News | Alnylam Canada Signs Letter of Intent From Pan-Canadian Pharmaceutical Alliance for the Public Reimbursement of Amvuttra® for the Treatment of Hereditary Transthyretin-Mediated (Hattr) Amyloidosis in Adults
H.C. Wainwright Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $400